Therapeutic Action
Cholinergic anti-glaucoma agent, miotic
PDF page 593
Loading InternPractice…
Drug reference
Cholinergic anti-glaucoma agent, miotic
PDF page 593
Chronic open-angle glaucoma
PDF page 593
Do not administer to children. Do not administer to patients with iridocyclitis and some forms of secondary glaucoma. Do not administer to patients with history of retinal detachment (trauma or family history) nor to myopic patients, except if it is possible to examine the peripheral retina (fundus examination) prior to the initiation of therapy and routinely thereafter. May cause: transient blurred vision, visual field modification, difficulty with dark adaptation (inform patients, especially drivers); retinal detachment in patients with myopia; ocular irritation, headache (decreasing after 2 to 4 weeks); rarely, allergic reactions. In case of treatment with another eye drop, wait 5 minutes before instilling the second eye drop treatment. Patients should have regular monitoring of intraocular pressure during therapy. Pregnancy: no contra-indication Breastfeeding: no contra-indication
PDF page 593
2% eye drops Also comes in 4% eye drops.
PDF page 593
Adult: 1 drop into the conjunctival sac 4 times daily
PDF page 593
Life-long treatment
PDF page 593
Do not touch the dropper with the hands.
PDF page 594
Below 25 °C Once the bottle has been opened, solution keeps for 2 weeks.
PDF page 594
1 drop into the conjunctival sac 4 times daily
PDF page 593